Merge of 4 Clinical Trials and Anagram

We are delighted to announce the merge of 4 Clinical Trials and Anagram, effective since April 10th, 2018.

4 Clinical Trials is a company born in 2016 with the aim to provide support to the international clinical reach world from different angles and works in partnership with IEC, Spanish leader in Image for clinical trials.

Anagram, founded in 1998, has a solid track record in supporting clinical trials in Spain, both with Investigational Products and Medical Devices.

The three companies have aligned to combine strengths and experience and offer a wider and more comprehensive range of services to their clients.

By having strong national and international background and efficiently combining Image Core lab and a robust project management and monitoring team, we can support our clients now better than ever.


Anagram in B-Debate, Barcelona ; 4th and 5th October

In clinical trials – throughout all the phases – timely patient recruitment is a constant concern and a key condition for the success of any concrete clinical study. About 80% of delays in clinical trial timelines are accounted for patient recruitment and retention, with over 50% of recruitment failing to meet the stipulated timeline.

Anagram will be presenting a poster  on How to improve patient retention in Clinical Trials, during the upcoming  B-Debate «From values to practice. Building a roadmap for transformative change»  (Barcelona ;  4th and 5th October) .

This event is part of the Open Science B-Debate organized by BioCat and Obra Social «La Caixa».

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

Aviso de cookies